These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6302127)

  • 1. Blunted plasma cyclic adenosine monophosphate response to isoproterenol in pseudohypoparathyroidism.
    Carlson HE; Brickman AS
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1323-6. PubMed ID: 6302127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal free fatty acid response to isoproterenol in pseudohypoparathyroidism.
    Carlson HE; Brickman AS; Burns TW; Langley PE
    J Clin Endocrinol Metab; 1985 Aug; 61(2):382-4. PubMed ID: 2989322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory adenylate cyclase coupling protein in pseudohypoparathyroidism.
    Downs RW; Sekura RD; Levine MA; Spiegel AM
    J Clin Endocrinol Metab; 1985 Aug; 61(2):351-4. PubMed ID: 2989320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension.
    Messerli FH; Kuchel O; Hamet P; Tolis G; Guthrie GP; Fraysse J; Nowaczynski W; Genest J
    Circ Res; 1976 Jun; 38(6 Suppl 2):42-7. PubMed ID: 178467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to glucagon infusion in pseudohypoparathyroidism.
    Brickman AS; Carlson HE; Levin SR
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1354-60. PubMed ID: 3023420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.
    Motulsky HJ; Hughes RJ; Brickman AS; Farfel Z; Bourne HR; Insel PA
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4193-7. PubMed ID: 6287473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.
    Bourne HR; Kaslow HR; Brickman AS; Farfel Z
    J Clin Endocrinol Metab; 1981 Sep; 53(3):636-40. PubMed ID: 6267099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudohypoparathyroidism: a generalized and multiple disorder in the adenyl cyclase system].
    Stögmann W
    Padiatr Padol; 1983; 18(3):243-6. PubMed ID: 6310469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib.
    Silve C; Santora A; Breslau N; Moses A; Spiegel A
    J Clin Endocrinol Metab; 1986 Apr; 62(4):640-4. PubMed ID: 3005354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient prolactin response to parathyroid hormone in hypocalcemic and normocalcemic pseudohypoparathyroidism.
    Kruse K; Gutekunst B; Kracht U; Schwerda K
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1099-105. PubMed ID: 6262363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient activity of receptor-cyclase coupling protein is transformed lymphoblasts of patients with pseudohypoparathyroidism, type I.
    Farfel Z; Abood ME; Brickman AS; Bourne HR
    J Clin Endocrinol Metab; 1982 Jul; 55(1):113-7. PubMed ID: 6281299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.
    Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoparathyroidism: inheritance and expression of deficient receptor-cyclase coupling protein activity.
    Fischer JA; Bourne HR; Dambacher MA; Tschopp F; De Meyer R; Devogelaer JP; Werder EA; Nagant De Deuxchaisnes C
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):747-54. PubMed ID: 6317236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.
    Zung A; Chalew SA; Schwindinger WF; Levine MA; Phillip M; Jara A; Counts DR; Kowarski AA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3576-81. PubMed ID: 8530601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dibutyryl adenosine 3',5'-monophosphate administration on plasma concentrations of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism type I.
    Yamaoka K; Seino Y; Ishida M; Ishii T; Shimotsuji T; Tanaka Y; Kurose H; Matsuda S; Satomura K; Yabuuchi H
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1096-100. PubMed ID: 6270183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode.
    Mann JJ; Halper JP; Wilner PJ; Sweeney JA; Mieczkowski TA; Chen JS; Stokes PE; Brown RP
    Biol Psychiatry; 1997 Nov; 42(10):859-70. PubMed ID: 9359970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.
    Puzhko S; Goodyer CG; Kerachian MA; Canaff L; Misra M; Jüppner H; Bastepe M; Hendy GN
    J Bone Miner Res; 2011 Oct; 26(10):2473-85. PubMed ID: 21713996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.